Literature DB >> 18763407

Regional public health emergency preparedness: the experience of Massachusetts Region 4b.

John Grieb1, Mary E Clark.   

Abstract

Historically, local public health in Massachusetts has been largely decentralized, with each town responsible for providing local public health services. After 9/11, the Massachusetts Department of Public Health (MDPH) began to plan for bioterrorism and other possible public health emergencies and found that having 351 separate departments made emergency planning difficult and dispersing of funds a challenge. To facilitate this process, MDPH created seven emergency preparedness regions and asked local public health departments to engage in joint planning. This article describes the formation of Region 4b and how the region came together to work on emergency preparedness issues. It also examines the organizational, financial, and planning challenges associated with organizing these towns as a unified entity.

Mesh:

Year:  2008        PMID: 18763407      PMCID: PMC2430641          DOI: 10.1177/003335490812300406

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  3 in total

1.  Regionalization in local public health systems: variation in rationale, implementation, and impact on public health preparedness.

Authors:  Michael A Stoto
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

2.  Regional collaboration among Urban Area Security Initiative regions: results of the Johns Hopkins urban area survey.

Authors:  Nicole A Errett; Calvin Bowman; Daniel J Barnett; Beth A Resnick; Shannon Frattaroli; Lainie Rutkow
Journal:  Biosecur Bioterror       Date:  2014 Nov-Dec

3.  The Power of Modeling in Emergency Preparedness for COVID-19: A Moonshot Moment for Hospitals.

Authors:  Kyan C Safavi; Ann L Prestipino; Ana Cecilia Zenteno Langle; Martin Copenhaver; Michael Hu; Bethany Daily; Allison Koehler; Paul D Biddinger; Peter F Dunn
Journal:  Disaster Med Public Health Prep       Date:  2021-02-16       Impact factor: 1.385

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.